Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Agergaard

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|March 31, 2010
[22q11 deletion syndrome: considerable phenotype variability]Peter Agergaard, Charlotte Olesen
American Journal of Medical Genetics. Part A|December 23, 2011
The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based studyPeter Agergaard, Charlotte Olesen, John Rosendahl Østergaard, et al.
American Journal of Medical Genetics. Part A|February 4, 2012
Chromosome 22q11.2 duplication is rare in a population-based cohort of Danish children with cardiovascular malformationsPeter Agergaard, Charlotte Olesen, John Rosendahl Østergaard, et al.
European Journal of Medical Genetics|October 23, 2010
Can clinical assessment detect 22q11.2 deletions in patients with cardiac malformations? A reviewPeter Agergaard, Anders Hebert, Karina M Sørensen, et al.
Clinical Epidemiology|March 10, 2011
Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient RegistryPeter Agergaard, Anders Hebert, Jesper Bjerre, et al.
The Journal of Pediatrics|June 2, 2016
Congenital Heart Defects and Measures of Fetal Growth in Newborns with Down Syndrome or 22q11.2 Deletion SyndromeNiels B Matthiesen, Peter Agergaard, Tine B Henriksen, et al.
Circulation|January 16, 2016
Congenital Heart Defects and Indices of Fetal Cerebral Growth in a Nationwide Cohort of 924 422 Liveborn InfantsNiels B Matthiesen, Tine B Henriksen, J William Gaynor, et al.
Circulation|October 16, 2016
Congenital Heart Defects and Indices of Placental and Fetal Growth in a Nationwide Study of 924 422 Liveborn InfantsNiels B Matthiesen, Tine B Henriksen, Peter Agergaard, et al.
The Journal of Molecular Diagnostics : JMD|January 16, 2010
Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samplesKarina M Sørensen, Peter Agergaard, Charlotte Olesen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 10, 2025
Predicting Surfactant Need at Birth: Failed Validation of a Bedside Method Using Gastric AspiratesChristian Heiring, Porntiva Poorisrisak, Niklas Breindahl, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|March 31, 2010
[22q11 deletion syndrome: considerable phenotype variability]Peter Agergaard, Charlotte Olesen
American Journal of Medical Genetics. Part A|December 23, 2011
The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based studyPeter Agergaard, Charlotte Olesen, John Rosendahl Østergaard, et al.
American Journal of Medical Genetics. Part A|February 4, 2012
Chromosome 22q11.2 duplication is rare in a population-based cohort of Danish children with cardiovascular malformationsPeter Agergaard, Charlotte Olesen, John Rosendahl Østergaard, et al.
European Journal of Medical Genetics|October 23, 2010
Can clinical assessment detect 22q11.2 deletions in patients with cardiac malformations? A reviewPeter Agergaard, Anders Hebert, Karina M Sørensen, et al.
Clinical Epidemiology|March 10, 2011
Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient RegistryPeter Agergaard, Anders Hebert, Jesper Bjerre, et al.
The Journal of Pediatrics|June 2, 2016
Congenital Heart Defects and Measures of Fetal Growth in Newborns with Down Syndrome or 22q11.2 Deletion SyndromeNiels B Matthiesen, Peter Agergaard, Tine B Henriksen, et al.
Circulation|January 16, 2016
Congenital Heart Defects and Indices of Fetal Cerebral Growth in a Nationwide Cohort of 924 422 Liveborn InfantsNiels B Matthiesen, Tine B Henriksen, J William Gaynor, et al.
Circulation|October 16, 2016
Congenital Heart Defects and Indices of Placental and Fetal Growth in a Nationwide Study of 924 422 Liveborn InfantsNiels B Matthiesen, Tine B Henriksen, Peter Agergaard, et al.
The Journal of Molecular Diagnostics : JMD|January 16, 2010
Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samplesKarina M Sørensen, Peter Agergaard, Charlotte Olesen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 10, 2025
Predicting Surfactant Need at Birth: Failed Validation of a Bedside Method Using Gastric AspiratesChristian Heiring, Porntiva Poorisrisak, Niklas Breindahl, et al.
Pageof 2